Testing the Addition of the Anti-cancer Drug, Cabozantinib, to the Usual Immunotherapy Treatment, Avelumab, in Patients With Metastatic Urothelial Cancer, MAIN-CAV Study
PHASE3
This phase III trial compares the effect of adding cabozantinib to avelumab...
A Study of Avelumab In Combination With Axitinib in Patients With Unresectable/Metastatic Gastrointestinal Stromal Tumor After Failure of Standard Therapy
PHASE2
To assess anti-tumor activity of avelumab in combination with axitinib in p...
Status
Completed
Location
Maria Sklodowska-Curie National Research Institue of Oncology
An Observational Chart Review Study To Describe The Real-World Outcomes And Use Of Avelumab In Combination With Axitinib For Treatment Of Patients With aRCC In The UK
N/A
An observational chart review study to describe the real-world outcomes and...